Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 12, 2017 | $0.09 | 2017-11-27 | 2017-11-28 |
| September 14, 2017 | $0.09 | 2017-08-25 | 2017-08-29 |
| June 22, 2017 | $0.34 | 2017-06-01 | 2017-06-05 |
| March 20, 2017 | $0.34 | 2017-02-28 | 2017-03-02 |
| December 20, 2016 | $0.34 | 2016-12-01 | 2016-12-05 |
Dividends Summary
- Teva Pharmaceutical Industries Limited American Depositary Shares has issued 58 dividend payments over the past 14 years
- The most recent dividend was paid 2884 days ago, on December 12, 2017
- The highest dividend payed out to investors during this period was $0.35 per share
- The average dividend paid during this period was $0.20 per share.
Company News
Alvotech received a Complete Response Letter (CRL) from the FDA for its biosimilar candidate AVT05, requiring resolution of certain manufacturing facility deficiencies before approval. The company expects to address the issues and work with the FDA, but has lowered its 2025 revenue and EBITDA projections.
Harel Insurance Investments & Financial Services Ltd. significantly increased its stake in Teva Pharmaceutical by purchasing 4.3 million shares, valued at approximately $75.64 million, making Teva its largest holding at 6.84% of its U.S. equity assets.
The Trump administration will exclude imported generic drugs from potential tariffs, bringing relief to pharmaceutical companies and Indian drugmakers who supply nearly half of U.S. generic prescriptions.
AbbVie's (ABBV) acquisition of Celsius Therapeutics is set to add the latter's lead pipeline candidate, CEL383, a potential first-in-class TREM1 inhibitor, to ABBV's pipeline.